Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir(R) therapy: A case report.

dc.contributor.authorPumpure, Elizabete
dc.contributor.authorDručka, Eva
dc.contributor.authorKigitoviča, Dana
dc.contributor.authorMeškauskas, Raimundas
dc.contributor.authorIsajevs, Sergejs
dc.contributor.authorNemiro, Ineta
dc.contributor.authorRasa, Agnija
dc.contributor.authorOlmane, Evija
dc.contributor.authorZablocka, Tatjana
dc.contributor.authorAlberts, Pēteris
dc.contributor.authorDoniņa, Simona
dc.date.accessioned2022-01-19T09:20:12Z
dc.date.available2022-01-19T09:20:12Z
dc.date.issued2020-05-22
dc.description.abstractPrimary malignant melanoma of the uterine cervix is a rare disease with poor prognosis and high recurrence rate. We used Rigvir® as adjuvant therapy for a stage IVA patient. Tolerability, overall and progression-free survival are good.en_US
dc.identifier.doihttps://doi.org/10.1002/ccr3.2928
dc.identifier.urihttps://dspace.rsu.lv/jspui/handle/123456789/7229
dc.language.isoenen_US
dc.relation.ispartofClinical Case Reports, 8(8), 1538-1543en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectECHO-7 virusen_US
dc.subjectmelanomaen_US
dc.subjectoncologyen_US
dc.subjectoncolytic virusen_US
dc.subjectRigviren_US
dc.subjectuterine cervixen_US
dc.titleManagement of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir(R) therapy: A case report.en_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir® therapy A case report.pdf
Size:
1.2 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections